Get the Stockscreener App
0.88
1.66%
-0.0149
Pre-market:
.88
Catheter Precision Inc. stock is traded at $0.88, with a volume of 15,963.
It is down -1.66% in the last 24 hours and down -6.38% over the past month.
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
See More
Previous Close:
$0.8949
Open:
$0.893
24h Volume:
15,963
Relative Volume:
0.02
Market Cap:
$2.37M
Revenue:
$819.00K
Net Income/Loss:
$-17.70M
P/E Ratio:
-0.0695
EPS:
-12.6647
Net Cash Flow:
$-8.45M
1W Performance:
+3.77%
1M Performance:
-6.38%
6M Performance:
-58.49%
1Y Performance:
-75.46%
1-Day Range:
$0.8374
$0.893
1-Week Range:
$0.8374
$0.9397
52-Week Range:
$0.7501
$15.68
Catheter Precision Inc. Stock (VTAK) Company Profile
Name
Catheter Precision Inc.
Sector
Industry
Phone
973 691 2000
Address
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.88 | 2.41M | 819.00K | -17.70M | -8.45M | -12.66 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-02-18 | Initiated | Maxim Group | Buy |
Catheter Precision Inc. Stock (VTAK) Latest News
Catheter Precision Inc. (VTAK) Q1 2025 Earnings: Significant EPS Miss and No Revenue ReportedPost-Earnings Reaction - thelegaladvocate.com
Catheter Precision Company Profile & Introduction - Moomoo
Catheter Precision (VTAK) Q1 2025 Earnings: Significant EPS Miss as Stock Rises Amid Strategic ProgressEPS Miss Report - Newser
Catheter Precision Inc. (VTAK) Gains 5.7% as Micro-Cap Stock Tests Resistance Near $0.88Volatility Breakout Picks - thelegaladvocate.com
VTAK Q1 2025 Earnings: Significant EPS Miss Amidst Operational ChallengesFinancial Data - thelegaladvocate.com
Catheter Precision reports net loss of USD 1.7M in Q1 2026 - Medical Buyer
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND - Yahoo Finance
Catheter Precision (NYSE: VTAK) triples Q1 revenue and adds Flyte aviation - Stock Titan
Catheter Precision, Inc. (VTAK) Q1 2026 10-Q Report: Financials, Warrants, and Segment Details - Minichart
Catheter Precision reports 200% revenue growth in Q1 2026 By Investing.com - Investing.com Nigeria
Catheter Precision reports 200% revenue growth in Q1 2026 - Investing.com
Catheter Precision Announces Brief 10-Q Filing Delay - TipRanks
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION - marketscreener.com
Medical device firm’s Q1 sales jump 200% after Flyte jet deal - Stock Titan
Catheter Precision, Inc. 1Q 2026: Revenue $432K, EPS ($1.39) — 10-Q Summary - TradingView
Catheter Precision: Revenue rose with FLYTE acquisition, but liquidity and dilution risks remain high - TradingView
Catheter Precision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Catheter Precision (NYSE: VTAK) adds aviation unit but flags going concern risk - Stock Titan
Catheter Precision (NASDAQ: VTAK) delays Q1 2026 10-Q after March 9 acquisitions - Stock Titan
Number of shareholders of Catheter Precision, Inc. – FWB:4RM - TradingView
Catheter Precision (VTAK) Q1 2025 Results Miss Estimates — EPS $-6.65 vs $-3.88EBITDA Margin Trends - Newser
VTAK Should I Buy - Intellectia AI
Catheter Precision (VTAK) 13G/A: Affiliates Report 0% Beneficial Ownership - Stock Titan
VTAK Stock Price, Quote & Chart | CATHETER PRECISION INC (NYSEARCA:VTAK) - ChartMill
FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND - The Manila Times
Sub-one-hour Preakness flights: Flyte offers I-95 alternative - Stock Titan
What Catheter Precision (VTAK) management is focused on executing | Q1 2025: Below ExpectationsSecondary Offering - newser.com
VTAK: Catheter Precision, Inc.Interactive Chart - Zacks Investment Research
Catheter Precision IncSpirit Airlines Shut - Moomoo
Spirit shutdown hit 17,000 workers; Flyte starts pilot hiring - Stock Titan
Catheter Precision, Inc. 2025 10-K/A Filing: Company Information, Filings Status, and Key Disclosures - Minichart
Catheter Precision : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Related-party financings reshape Catheter Precision (NYSE: VTAK) structure - Stock Titan
Catheter Precision’s Flyte expands jet fleet for summer routes By Investing.com - Investing.com India
Catheter Precision’s Flyte expands jet fleet for summer routes - Investing.com
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand - Yahoo Finance
New Charter Service Coming to Newport State Airport - Newport This Week
Catheter Precision Raises Capital Through New Preferred Stock - TipRanks
Catheter Precision (NYSE: VTAK) adds $3.47M and Flyte deal stock - Stock Titan
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting - marketscreener.com
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm ... - Bluefield Daily Telegraph
VTAK Catheter Precision shares rise 6.79 percent as 95 percent year over year revenue growth offsets weak Q1 2025 earnings.Expert Breakout Alerts - Xã Thanh Hà
Catheter Precision receives patent allowance for vessel closing device By Investing.com - Investing.com India
Catheter Precision (VTAK) Secures Notice of Allowance for Surgical Device Patent - GuruFocus
Catheter Precision receives patent allowance for vessel closing device - Investing.com
Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy - The Manila Times
Patent allowance gives LockeT surgical technology broader protection - Stock Titan
Catheter Precision Inc. Stock (VTAK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
1.94%
Cap:
|
Volume (24h):